Bayview Pharmacy is pleased to present a specially compounded topical cream that contains Azelastine Hydrochloride 0.15% and Brimonidine Tartrate 0.5%. This unique formulation is designed to address a range of conditions, including allergic conjunctivitis, vernal keratoconjunctivitis, and ocular itching associated with allergic conjunctivitis.

Azelastine Hydrochloride is an antihistamine that functions by inhibiting the action of histamine, a substance in the body that triggers allergic symptoms. On the other hand, Brimonidine Tartrate is an alpha-2 agonist that operates by reducing the amount of fluid in the eye, thereby minimizing redness and swelling. The combination of these two medications offers effective relief from the symptoms of allergic conjunctivitis, vernal keratoconjunctivitis, and ocular itching associated with allergic conjunctivitis.

This compounded formulation is a semisolid preparation dispensed in a pump mechanism, designed for convenient and controlled application on the skin for localized treatment or absorption of active ingredients. It is intended to be applied to the affected area twice daily, or as directed by a healthcare provider. It is crucial to adhere to the instructions provided by the healthcare provider and to avoid contact with the eyes.

Bayview Pharmacy is committed to ensuring the safety and efficacy of this formulation when used as directed. If you have any questions about this formulation or how it can assist in treating your condition, please do not hesitate to contact us at Bayview Pharmacy. We are here to help you identify the most suitable treatment option for your specific needs.

Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream is a compounded formulation designed for the treatment of allergic conjunctivitis, vernal keratoconjunctivitis, and blepharitis. This unique combination of active ingredients works synergistically to block the release of histamine, a chemical that triggers inflammation and itching, and to decrease the production of tears, providing relief from these conditions.

The cream is dispensed in a pump mechanism, which allows for convenient and controlled application on the skin. It is intended for localized treatment, meaning it should be applied directly to the affected area. The recommended dosage is twice daily, or as directed by your healthcare provider. It is crucial to avoid contact with the eyes, nose, and mouth. In case of accidental contact, rinse the area thoroughly with water.

Patients should be aware of potential side effects, which may include temporary blurred vision, stinging, burning, or redness at the application site. If these side effects persist or worsen, it is recommended to contact your healthcare provider immediately.

It is also important to note that this medication should not be used in patients with a known hypersensitivity to either Azelastine HCl or Brimonidine Tartrate. Furthermore, it should not be used in combination with other topical medications or with contact lenses, as this may increase the risk of side effects or cause irritation.

If you have any questions or concerns about the use of Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream, please do not hesitate to reach out to your healthcare provider for further guidance.

Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream is a compounded medication designed to treat conditions such as allergic conjunctivitis, vernal keratoconjunctivitis, and seasonal allergic rhinitis. This combination medication works by inhibiting the action of certain natural substances that trigger inflammation and redness in the eyes and nose. The azelastine hydrochloride component of the cream helps to alleviate itching, redness, and tearing of the eyes, while the brimonidine tartrate component aids in reducing redness and swelling of the eyes.

To use this medication, apply a thin layer of the cream to the affected area of the eye or nose, typically twice daily or as directed by your healthcare provider. The cream should be gently rubbed into the skin until it is fully absorbed. It is crucial to adhere to the recommended dose and not to use it more frequently than prescribed by your doctor.

Before using Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream, it is essential to inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. It is equally important to disclose any other medications you are currently taking, including vitamins and supplements, to your doctor.

If you have any queries about using Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream, do not hesitate to reach out for further information and guidance.

This Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream is a compounded formulation designed for localized treatment or absorption of active ingredients through the skin. It is dispensed in a pump mechanism for convenient and controlled application. This formulation may be used to treat a variety of ocular conditions including dry eye syndrome, corneal ulcers, and blepharospasm. It may also be beneficial in reducing the risk of corneal neovascularization, corneal scarring, infection in patients with ocular trauma, inflammation, corneal edema, corneal thinning, and corneal opacity.

Patients should be aware that this formulation may cause side effects such as burning, stinging, and redness of the eyes. If any of these side effects occur, it is recommended to contact a healthcare provider. Furthermore, prescribers should note that this formulation may interact with other medications and should be used with caution in patients with a history of glaucoma or other ocular conditions. For any questions or concerns regarding the use of this formulation, please consult with a healthcare professional.